Methods: At each of 9 data collection waves (age 21 retention: 91%), panel participants completed a survey about primary intervention outcomes (substance use, ASB, and violence), risk and protective factors, and secondary outcomes (e.g., mental health, sexual risk behavior). We analyzed CTC effects on lifetime onset of or abstinence from primary outcomes through age 21 among panel participants who had not onset at baseline. We used generalized linear mixed models to account for nesting and included covariates at individual (e.g., age, gender) and community (e.g., size) levels. We examined long-term intervention effects in the full sample and in males and females separately.
Results: Young adults exposed to CTC were significantly more likely to never have used gateway drugs (ARR=1.49, p =.037) or engaged in ASB (ARR=1.18, p =.034) or ever initiated violence (ARR= 0.89, p =.049). As at age 19, differences were significant for males (gateway drug use ARR = 1.661, p =.033; antisocial behavior ARR = 1.33, p = .032, violence ARR = 0.86, p = .020) but not females. Males also were more likely to never have engaged in cigarette smoking (ARR= 1.30, p =.013) or marijuana use (ARR= 1.24, p =.029) or ever have initiated inhalant use (ARR= 0.82, p =.032). Long-term effects were not found for recent ASB and substance use prevalence, substance use disorder, or secondary outcomes.
Conclusions: Eleven years after baseline, panel males from CTC communities still reported greater abstinence from several health risking behaviors, but evidence for long-term CTC effects in females was not found. Implications for refinement of CTC and effective preventive approaches for young adults will be discussed.